Sun Pharmaceutical Industries Limited — Updates, 26-11-2025: Press Release
26-11-2025 | 08:54 am
26-11-2025 | 08:54 am
Sun Pharma's UNLOXCYT received FDA label update for advanced CSCC, showing improved clinical outcomes and durable responses. As the first PD-L1 inhibitor, this strengthens its market position, enhancing future revenue potential.
No comments yet. Be the first to comment!
All announcements from Sun Pharmaceutical Industries Limited
